Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

NCT04673396 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Norcantharidin Lipid Microsphere for Injection
DRUG: Sodium Demethylcantharidate Injection

Sponsor

Beijing Nuokangda Pharmaceutical Technology Co., Ltd.